Léčivé přípravky s obsahem účinné látky Apadamtasa alfa a cinaxadamtasa alfa
Opportunity Score
Why this score?
Opportunity
60 / 100
Complexity
30 / 100
Risk factors
Deadline is about 1 month from notice publication, requiring prompt preparation.
Submission in Czech only, excluding non-Czech speakers.
Submission deadline in 13 days
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- CZK 23.3M estimated value
- Supplies contract
- 1 lot
- Periodic supplies of medicinal products with active substances Apadamtasa alfa and cinaxadamtasa alfa, strength 1500IU, in specified packaging.
- Deliveries based on partial orders issued as per buyer's current needs over 2 years.
Show full summary
Open tender by Krajská nemocnice Liberec, a.s. for periodic supplies of medicinal products containing active substances Apadamtasa alfa and cinaxadamtasa alfa (1500IU vial, packaging 1+5ML+BAXJECT+STŘ) over 2 years. Single lot, award based on lowest price (100% weight). Estimated value CZK 23,302,000. Submission deadline 2026-07-07 08:00 UTC. Electronic submission required, language Czech. Place of performance: Liberec region (CZ051). Procurement documents available via NEN portal; selection criteria not detailed in provided data.
Risks
Deadline is about 1 month from notice publication, requiring prompt preparation.
Submission in Czech only, excluding non-Czech speakers.
Submission deadline in 13 days
Key Requirements
Administrative
- Supply of pharmaceutical products meeting specification in procurement documents and price form (Appendix 2).
- Electronic submission required via buyer's profile on NEN portal.
- Submission language: Czech only.
Award Criteria
Lot 1
Buyer
Name
Krajská nemocnice Liberec, a.s.
Location
Liberec, CZE
Website
Buyer profile
Identifier
27283933
Lots (1)
LOT-0001
Léčivé přípravky s obsahem účinné látky Apadamtasa alfa a cinaxadamtasa alfa
Periodic deliveries of medicinal products with active substances Apadamtasa alfa and cinaxadamtasa alfa, strength 1500IU in vial, packaging 1+5ML+BAXJECT+STŘ. Duration 2 years based on partial orders.
CZK 23.3M
Estimated value
Location
Category
Deadline
Award details
Additional CPV codes
Value note
Show original TED data
Original TED description
Předmětem veřejné zakázky jsou průběžné dodávky léčivých přípravků s obsahem účinné látky Apadamtasa alfa a cinaxadamtasa alfa o síle 1500IU v injekční lahvičce v balení 1+5ML+BAXJECT+STŘ (dále jen „léčivé přípravky“ nebo také „zboží“). Specifikace požadovaného léčivého přípravku je uvedena v ZD a ve formuláři cenové nabídky, který je přílohou č. 2 této ZD. Průběžné dodávky léčivých přípravků budou uskutečňovány na základě dílčích objednávek vystavovaných dle aktuálních potřeb zadavatele po dobu dvou let ode dne nabytí účinnosti Kupní smlouvy.
Procurement Details
- Publication date
- 03 Jun 2026
- Notice type
- Contract notice — standard
- Languages
- Czech
Reference metadata
- Notice subtype
- 16
- Notice version
- 1
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 384740-2026
- Source notice ID
- a933ab8b-e4d2-4983-8a48-1d176715cdf9
Documents (2)
Similar tenders
Romania – Various medicinal products – Acor Cadru de Furnizare Diverse Medicamente si Ambalaje Farmaceutice
Poland – Various medicinal products – ZP.220.99.26 Dostawa różnych produktów leczniczych, żywności medycznej oraz preparatów do żywienia pacjentów na potrzeby
Poland – Pharmaceutical products – Dostawa produktów leczniczych do SPZZOZ w Wyszkowie
Poland – Antineoplastic agents – Dostawa produktów leczniczych i wyrobów medycznych do Wojskowego Instytutu Medycznego – PIB
Poland – Antineoplastic agents – Leki onkologiczne i sprzęt pomocniczy
Poland – Antithrombotic agents – Dostawa produktów leczniczych do leczenia zaburzeń w funkcjonowaniu przewodu pokarmowego, środków antybakteryjnych do użytku ogólnoustrojowego (...) w podziale na 21 części.
Opportunity Score
Why this score?
Opportunity
60 / 100
Complexity
30 / 100
Risk factors
Deadline is about 1 month from notice publication, requiring prompt preparation.
Submission in Czech only, excluding non-Czech speakers.
Submission deadline in 13 days
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications